Skip to main content

Clsi M22a3 Pdf __exclusive__ Jun 2026

The primary goal of M22-A3 is to streamline quality control (QC) by identifying media that have a historically low failure rate (defined as

Compliance isn't just about passing inspections; it's about patient safety. The CLSI M22-A3

Even for exempt media, users must still check for obvious defects like: Cracked plates or agar detachment. Unequal filling or frozen/melted agar. Hemolysis in blood-containing media. Archived but Valid:

Relation to other CLSI standards

Perform rigorous batch testing using specific ATCC control strains.

Verify that the manufacturer’s Certificate of Quality matches the lot numbers received.

CLSI M22-A3 standard, titled "Quality Control for Commercially Prepared Microbiological Culture Media; Approved Standard—Third Edition," clsi m22a3 pdf

The CLSI M22A3 PDF document is a valuable resource for clinical microbiology laboratories, providing comprehensive guidelines for antimicrobial susceptibility testing. Its standardized methods, interpretive criteria, and quality control recommendations help ensure accurate and reliable results. While it may require specialized knowledge to fully understand and apply the guidelines, the document is an essential tool for laboratories seeking to provide high-quality antimicrobial susceptibility testing. I highly recommend the CLSI M22A3 PDF document to laboratory professionals, researchers, and healthcare providers seeking to stay up-to-date with best practices in antimicrobial susceptibility testing.

The "exempt" status means that if a laboratory receives a lot of media from a commercial manufacturer that has already performed QC (evidenced by a Certificate of Quality), the lab only needs to perform physical inspections

Demonstrating that the media successfully supports the growth of the target organism (e.g., testing Sheep Blood Agar with Streptococcus pneumoniae to observe typical growth and beta-hemolysis). The primary goal of M22-A3 is to streamline

Utilize temperature indicators in shipping containers and enforce strict visual inspection protocols upon delivery. Conclusion

M22-A3 emphasizes that no system is 100% accurate for all NFB species.

The end-user laboratory must perform full quality control testing on every new lot number received, regardless of the manufacturer’s certificate. Hemolysis in blood-containing media

Understanding CLSI M22-A3: The Standard for Quality Control of Microbiological Culture Media